EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease

Clinical trial NCT07168603 · RECRUITING

Trial details

NCT number: NCT07168603
Sponsor: ASTEROGENE Biomedical Co. Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Intervertebral Disc Degeneration

Start date: 2025-09-26
Primary completion: 2026-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.